Literature DB >> 3972237

Duodenal ulcerogens cysteamine and propionitrile induce gastroduodenal motility alterations in the rat.

G Pihan, T J Kline, N K Hollenberg, S Szabo.   

Abstract

The effects of the duodenal ulcerogens cysteamine and propionitrile on gastroduodenal myoelectric activity and intraluminal pressure in the fasted rat as well as on contractility of isolated gut muscle strips were investigated. Duodenal ulcerogens, unlike the nonulcerogen but toxic analogue ethanolamine, caused an early disruption of the myoelectric migrating complex, a marked increase in the spiking activity, and a decrease in the frequency of the slow waves in the duodenum. Both the increased spiking activity and the decreased slow wave frequency were dose dependent for cysteamine. Manometrically recorded contractions at the stomach corpus, midantrum, and antropyloric region as well as in the proximal duodenum of the conscious rat showed decreased contractions at the corpus and midantrum and an increase at the pyloric and duodenal sites during an intravenous infusion of cysteamine. In vitro studies demonstrated that circularly or longitudinally cut muscle strips taken from different regions of the stomach and duodenum responded to cysteamine with increased contractility. In summary, the duodenal ulcerogens cysteamine and propionitrile rapidly induce motor abnormalities in the stomach and duodenum of the rat. In vitro studies suggest that a cholinergic mechanism may be involved. It is possible that motor changes play a role in the pathogenesis of the experimentally induced duodenal ulcers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3972237     DOI: 10.1016/s0016-5085(85)80019-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

1.  Modulation of gastric motility by brain-gut peptides using a novel non-invasive miniaturized pressure transducer method in anesthetized rodents.

Authors:  Guillaume Gourcerol; David W Adelson; Mulugeta Million; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2011-01-22       Impact factor: 3.750

2.  MPTP, gastroduodenal motility, duodenal ulceration, and Parkinson's disease.

Authors:  S Szabo
Journal:  Dig Dis Sci       Date:  1990-05       Impact factor: 3.199

3.  Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats.

Authors:  J C Mangla; G Pihan; H A Brown; S Rattan; S Szabo
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

4.  Effects of dopamine on gastric mucosal lesions induced by ethanol in rats. Possible involvement of antigastric motor activity mediated with alpha 2-adrenoceptors.

Authors:  K Takeuchi; H Nishiwaki; S Okabe
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

5.  Cysteamine-induced inhibition of mucosal and pancreatic alkaline secretion in rat duodenum.

Authors:  K Ohe; Y Miura; Y Taoka; Y Okada; A Miyoshi
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

6.  Gastric and duodenal anti-ulcer activity of sulpiride, a dopamine D2 receptor antagonist, in rats.

Authors:  J K Desai; N S Parmar
Journal:  Agents Actions       Date:  1994-10

7.  Biphasic effect of duodenal ulcerogens on gastric emptying in the rat.

Authors:  T J Kline; G Pihan; S Szabo
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

Review 8.  From peptic ulcer disease to NSAID gastropathy. An evolving nosology.

Authors:  S H Roth
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

9.  Effects of compound U74500A in animal models of gastric and duodenal ulceration.

Authors:  A Krantis; R K Harding; A E McKay; G P Morris
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

10.  Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats.

Authors:  K Takeuchi; H Nishiwaki; S Okabe
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.